In the study by Afrin R. et al., curcumin reduced the progression of steatohepatitis in a mouse model of HCC-NASH by inhibiting HMGB1-NF-κB nuclear translocation. Here, NFKB1 is linked to metabolic dysfunction-associated steatohepatitis.